company background image
MPH logo

Medicure TSXV:MPH Stock Report

Last Price

CA$1.20

Market Cap

CA$12.5m

7D

4.3%

1Y

20.0%

Updated

27 Mar, 2024

Data

Company Financials

MPH Stock Overview

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market.

MPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Medicure Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medicure
Historical stock prices
Current Share PriceCA$1.20
52 Week HighCA$1.80
52 Week LowCA$0.93
Beta1.01
1 Month Change8.11%
3 Month Change-11.11%
1 Year Change20.00%
3 Year Change-22.08%
5 Year Change-80.65%
Change since IPO-88.89%

Recent News & Updates

Investors Don't See Light At End Of Medicure Inc.'s (CVE:MPH) Tunnel

Mar 08
Investors Don't See Light At End Of Medicure Inc.'s (CVE:MPH) Tunnel

Recent updates

Investors Don't See Light At End Of Medicure Inc.'s (CVE:MPH) Tunnel

Mar 08
Investors Don't See Light At End Of Medicure Inc.'s (CVE:MPH) Tunnel

We Ran A Stock Scan For Earnings Growth And Medicure (CVE:MPH) Passed With Ease

Aug 28
We Ran A Stock Scan For Earnings Growth And Medicure (CVE:MPH) Passed With Ease

Medicure's (CVE:MPH) Earnings Are Weaker Than They Seem

Nov 30
Medicure's (CVE:MPH) Earnings Are Weaker Than They Seem

Here's Why Shareholders Should Examine Medicure Inc.'s (CVE:MPH) CEO Compensation Package More Closely

Jun 15
Here's Why Shareholders Should Examine Medicure Inc.'s (CVE:MPH) CEO Compensation Package More Closely

Shareholder Returns

MPHCA BiotechsCA Market
7D4.3%1.4%0.4%
1Y20.0%-26.0%9.0%

Return vs Industry: MPH exceeded the Canadian Biotechs industry which returned -28.6% over the past year.

Return vs Market: MPH exceeded the Canadian Market which returned 9% over the past year.

Price Volatility

Is MPH's price volatile compared to industry and market?
MPH volatility
MPH Average Weekly Movement19.2%
Biotechs Industry Average Movement12.4%
Market Average Movement8.5%
10% most volatile stocks in CA Market18.4%
10% least volatile stocks in CA Market3.1%

Stable Share Price: MPH has not had significant price volatility in the past 3 months.

Volatility Over Time: MPH's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
1997n/aAlbert Friesenhttps://www.medicure.com

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia.

Medicure Inc. Fundamentals Summary

How do Medicure's earnings and revenue compare to its market cap?
MPH fundamental statistics
Market capCA$12.52m
Earnings (TTM)CA$1.08m
Revenue (TTM)CA$22.94m

11.6x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MPH income statement (TTM)
RevenueCA$22.94m
Cost of RevenueCA$6.96m
Gross ProfitCA$15.98m
Other ExpensesCA$14.90m
EarningsCA$1.08m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.10
Gross Margin69.68%
Net Profit Margin4.71%
Debt/Equity Ratio0%

How did MPH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.